Glucose restriction decreases telomerase activity and enhances its inhibitor response on breast cancer cells: possible extra-telomerase role of BIBR 1532 by Layal Wardi et al.
Wardi et al. Cancer Cell International 2014, 14:60
http://www.cancerci.com/content/14/1/60PRIMARY RESEARCH Open AccessGlucose restriction decreases telomerase activity
and enhances its inhibitor response on breast
cancer cells: possible extra-telomerase role of
BIBR 1532
Layal Wardi1, Nada Alaaeddine2, Issam Raad3, Riad Sarkis4, Rim Serhal2, Charbel Khalil2 and George Hilal1*Abstract
Background: Considerable progress has been made to understand the association between lifestyle and diet in
cancer initiation and promotion. Because excessive glucose consumption is a key metabolic hallmark of cancer
cells, glucose restriction (GR) decreases the proliferation, and promotes the differentiation and transformation of
cancer cells to quiescent cells. The immortality of cancerous cells is largely assured by telomerase, which is an
interesting target for inhibition by BIBR 1532. In this study, we investigated the effect of GR on telomerase activity
and on the efficacy of its inhibition by BIBR 1532.
Methods: Breast cancer MDA-MB 231 and MCF-7 cells were cultured in DMEM (Dulbecco’s modified eagle’s media)
with 0, 1 or 4.5 g/l of glucose. The telomerase activity was measured via quantitative Real-Time PCR, and the two
telomerase subunits were semi-quantified by RT-PCR. Proliferation test and mitochondrial metabolism were assessed
via tetrazolium salt reduction and cell counts; apoptosis was assessed via caspase-3 quantification and flow
cytometry.
Results: A decrease in the telomerase activity of more than 75% was associated with a significant reduction in the
mRNA expression of its catalytic subunit hTERT (Reverse Transcriptase) and a decrease in the mitochondrial
metabolism by more than 80% under restricted glucose conditions. In addition, GR increased the effect of BIBR
1532. Glucose deprivation induces apoptosis via BIBR 1532-mediated telomerase inhibition in triple negative breast
cancer cells, as assessed by caspase-3 measurements and Annexin analysis.
Conclusions: Taken together, our results suggest that the effect of BIBR 1532 is potentiated by GR to induce triple
negative breast cancer cell death.
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Caloric restriction (CR) or reducing the total caloric intake
by 20 to 40% without limiting essential vitamins and min-
erals has long been considered as a means to prevent and
cure cancer and to extend life span [1-3]. Recently, a po-
tential role of CR in the treatment and intervention of age-
related diseases, including cardiovascular disease, diabetes,* Correspondence: george.hilal@usj.edu.lb
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gated [4,5].
Cancer is a complex disease associated with multiple
DNA mutations that lead to abnormal cell proliferation,
immortality and tissue invasion at distant sites [6]. The
strong relationship between nutrition and cancer, as also
demonstrated by several epidemiological studies [7,8],
has been extrapolated by some clinicians into complete
abstinence from food. In fact, ten oncologists did allow
their patients who suffered from breast, esophageal, pros-
tate and lung cancer to fast from 48 to 140 hours pre-
chemotherapy and 5 to 56 hours post chemotherapy [9].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ing reported a reduction in side effects and also showed a
better response to treatment than the control group. This
latter observation contradicts the dietary recommendation
of the American Cancer Society that advises patients to
increase their protein and calorie intake before chemo-
therapy administration.
Cell division is potentially a risky process, and cell div-
ision is limited in normal tissues. Telomerase is up-
regulated in 85% of malignant tumors. Therefore, they
escape senescence to have unlimited cell division at the
earlier stage of tumorogenesis [10]. Telomerase is the
key enzyme responsible for the immortalization of can-
cerous cells [11].
Telomerase is a ribonucleoprotein complex enzyme
that consists of two major subunits, the human Telomer-
ase Reverse Transcriptase (hTERT) and human RNA com-
ponent (hTR), in addition to several accessory proteins
that modulate the activity of this enzyme [12]. Eighty five
percent of malignant tumors escape senescence to have
unlimited cell division following telomerase up-regulation
during the early stages of tumorogenesis [10]. The enzyme
telomerase stabilizes the length of telomeres, the end of
linear chromosomes, via the de novo addition of telomeric
repeats, which have been lost during incomplete DNA
replication, telomere degradation or oxidative stress. The
telomerase-induced telomere maintenance and reparation
is believed to play a critical role in senescence, aging and
cancer [13]. Human telomerase consists of two major sub-
units, the human Telomerase Reverse Transcriptase
(hTERT) and human RNA component (hTR), in addition
to several accessory proteins that modulate the activity of
this enzyme [12].
An increasing body of literature has demonstrated that
several metabolic changes occur during cancer evolution
[14]. On the molecular level, cancer cell proliferation is
tightly related to cell metabolism [15]. In multicellular
organisms, cell proliferation is controlled, and any aber-
rant individual cell proliferation is prevented when nu-
trients exceed the levels needed to support cell division.
In contrast, cancer cells overcome this growth factor
control via several DNA mutations that alter the receptor-
initiated signaling pathway [16,17]. This altered metabol-
ism of tumor cells is exhibited by an increased glucose
uptake and elevated aerobic glycolysis, which was first
recognized by Warburg 70 years ago [18]. Unsurprisingly,
abnormal glucose metabolism has become the target of
several studies because of its uniqueness in cancer cells
and its possible role in preventing and curing cancer.
However, GR is a metabolic stressor to many signaling
pathways, including the anti-apoptotic pathway IGF1R-IR/
PI3K/Akt/mTOR [19]. Glycolytic enzymes are up-regulated
following the activation of this pathway. In addition to gly-
colysis activation, c-Myc and SP1, which are transcriptionfactors induced by a high glucose level, cooperate to acti-
vate the transcription of the catalytic subunit of telomer-
ase (hTERT) [20] The activation of AMP-activated protein
kinase by GR down-regulates mTOR, glycolysis activity,
and cell proliferation [21-23]. Furthermore, glucose with-
drawal increases ketone bodies in the blood circulation.
These ketone bodies can reportedly help to prevent and
treat cancer by protecting mitochondria from inflamma-
tion and ROS (Reactive Oxygen Species) [24]. Finally, Li
and colleagues [25] demonstrated that GR impairs precan-
cerous cell growth via the epigenetic control of the tel-
omerase subunit (hTERT) and p16 expression.
GR is an attractive modality to explore because it has
been shown to induce changes in molecular pathways,
especially those altered in cancer. Altering these path-
ways could make cells more susceptible to treatment
with the telomerase inhibitor BIBR 1532. This drug is a
potent and selective inhibitor of two telomerase units; it
interferes with the action of telomerase [26].
The primary objective of this article was to investigate
the effect of GR on the telomerase activity and on its in-
hibition by BIBR1532 in two breast cancer cell lines, the
highly invasive and metastatic triple-negative (ER-, PR-,
Her2-) MDA-MB 231 and the less invasive Estrogen-
dependent (ER+) MCF-7 cells.
Results
Effect of glucose restriction (GR) on telomerase activity
The effect of GR on the telomerase activity was first
assessed using the MDA-MB 231 and MCF-7 breast
cancer cell lines. Figure 1 shows that decreasing the glu-
cose concentration in culture media led to a partial tel-
omerase activity inhibition at 1 and 0 g/l. Importantly,
the cells incubated with 0 g/l of glucose were cultured in
10% of FBS that contains 0.65 g/l of glucose. This con-
centration was measured for each test in a medical la-
boratory and mimics physiological glycaemia in fasting
situations. MDA-MB 231 reduced their telomerase activ-
ity in response to GR by more than 50% (P < 0.05) and
80% (P < 0.01) at 1 g/l and 0 g/l of glucose, respectively.
This same pattern was evident in MCF-7 cells, as indi-
cated in Figure 1b. The telomerase activity decreased by
40% and 75% in cells incubated in DMEM containing
1 g/l (P < 0.05) and 0 g/l glucose (P < 0.01), respectively.
Glucose restriction but not BIBR 1532 impaired hTERT
expression
Because the hTR component is constitutively expressed
in all cells and hTERT is up-regulated in most tumor
cells, we investigated the ability of GR to modulate the
expression of hTERT in human breast cancer cell lines
after 48 h of treatment with 10 μM BIBR1532. The RT-
PCR method was used to examine the expression of both
hTR and hTERT mRNA using GAPDH as an internal
Figure 1 Effect of GR on the telomerase activity. a. MDA-MB 231 and b. MCF-7 cells were seeded in 75 cm2 flasks and grown in DMEM culture
medium containing 10% FBS and 1% Pen/Strep at different glucose concentrations (0, 1 and 4.5 g/L of glucose). After 5 days of pre-incubation in
the appropriate medium 1.5 million cells of each condition were prepared for the telomerase activity and protein measurements. The bars
represent values from at least three independent experiments (*P < 0.05, **P < 0.01).
Wardi et al. Cancer Cell International 2014, 14:60 Page 3 of 14
http://www.cancerci.com/content/14/1/60control. Importantly, BIBR 1532 inhibits the protein, but
not the mRNA level of hTERT; it inhibits the mechanism
of action of the enzyme.
The relatively high telomerase activity at high glucose
concentrations shown in Figure 1 was confirmed by high
mRNA expression (Figure 2). However, we could not
demonstrate any changes in the expression of hTERT
and hTR mRNA in cells grown in 1 and 0 g/l of glucose;
hTERT was expressed at 55% (P = 0.0248) and 59%
(P = 0.033) at 1 and 0 g/l of glucose, respectively, in MDA-
MB 231, while hTERT was expressed at 41% (P = 0.021)
and 37% (P = 0.0178) in 0 g/L and 1 g/L, respectively, in
MCF-7 cells, as shown in Figure 2c. As expected, BIBR
1532 did not affect the telomerase transcription because it
acts directly on the protein.Glucose restriction decreased cell proliferation and
enhanced the effect mediated by BIBR 1532
The effect of GR on the MDA-MB 231 cell count and
proliferation was only significant at 0 g/l of glucose com-
pared to 4.5 g/l of glucose, as shown in Figure 3a. Al-
though cell proliferation at 1 g/l of glucose seems to be
lower compared to cells grown in 4.5 g/l of glucose, the
results did not reach significance (P = 0.08). In contrast,
the proliferation of cells in 0 g/l of glucose was very
slow, and this difference was statistically very significant
compared to those incubated in 1 and 4.5 g/l of glucose
(P < 0.001). The effect of the telomerase inhibitor BIBR
1532 was very pronounced for cells grown in 0 g/l of
glucose. By the end of week three, the number of cells
incubated in 0 g/l of glucose and 2.5 μM BIBR 1532 was
Figure 2 Regulation of hTERT mRNA expression by 10 μM BIBR 1532 in MDA-MB-231 and MCF-7 cells. Cells grown in different glucose
concentrations were treated with telomerase inhibitor for 48 h. The effect of 10 μM BIBR 1532 on gene expression was examined by RT-PCR.
Aliquots of each reaction were equalized as shown by the internal control of GAPDH. a and c show the effect of GR and BIBR 1532 treatment on
the hTERT mRNA expression in MDA-MB 231 and MCF-7, respectively. The relative expression levels of hTERT at different glucose concentrations
are shown in b and d. The result presented represents three independent experiments. (*P < 0.05, **P < 0.01).
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1532 seemed to have an effect in weeks one and two for
cells grown in 1 and 4.5 g/l of glucose. This trend disap-
peared at week three, and the level of cell proliferation
was similar to that of the control.
The effect of GR was more pronounced on the MCF-7
cell line. As shown in Figure 3b, reducing the glucose
concentration in the media significantly decreased the
cell proliferation over time. The proliferation of cells
grown without glucose reduced by 30% from the first
week (P = 0.057), and this reduction was enhanced at the
second week, when only less than 40% of cells remained
alive (P = 0.0001). The MCF-7 cell count was not ex-
tended into the third week because all of the cells grown
in DMEM containing 0 g/L of glucose had died. Cells in-
cubated in 1 g/L of glucose exhibited reduced prolifera-
tion by 20% at the second week (P = 0.0139). After
15 days, 2.5 μM BIBR 1532 could reduce cell prolifera-
tion by 35% only when cells were incubated in physio-
logical glucose concentrations (P = 0.0051).
Regulation of mitochondrial metabolism by glucose
restriction and BIBR 1532
Water-soluble tetrazolium salt WST-1 was used to as-
sess the cell viability. This test reflects not only the cell
viability but also the metabolism of mitochondria, as re-
ported by several works [27,28]. Figure 4a shows that
GR apparently decreased the succinate reductase activity
in MDA-MB 231 cells by 55% and by more than 5-foldfor cells grown in 1 g/l and 0 g/l of glucose, respectively.
In MCF-7 cells, GR reduced the mitochondrial activity
by 35% and by more than 80% in cells grown in 1 g/l
and 0/gl glucose, respectively (P = 0.0009). This decrease
was not caused by cell death because healthy quasi-
confluent cells were detected in all wells using micro-
scopic examination, bromophenol blue staining, and cell
counts. This experiment was extended to evaluate the
effect of BIBR 1532 in the GR conditions. As shown in
Figure 5a, BIBR 1532 significantly reduced succinate re-
ductase activity in MDA-MB 231 cells grown in 1 g/L
and 4.5 g/L glucose. This effect was potentiated at a high
glucose level (4.5 g/L), where 10 μM BIBR 1532 could
reduce WST-1 transformation by 35%. However, this ef-
fect was absent when cells were grown in 0 g/l glucose.
As shown in Figure 5b, higher concentrations of BIBR
1532 are required to elicit the same effect observed in
MDA-MB 231 cells. This telomerase inhibitor could re-
duce WST-1 transformation by 25% starting from 50 μM,
and this reduction became more significant when the
BIBR 1532 concentration was increased to 100 μM
(P = 0.0011). A high concentration of BIBR 1532 (100 μM)
is required to inhibit the mitochondrial metabolism
by ~25% in cells incubated in 1 g/L of glucose (P = 0.029).
This modulator effect was absent in cells grown without
glucose.
Telomerase-negative human osteosarcoma Saos-2 cells
have previously been studied to examine the role of tel-
omerase in mitochondrial metabolism modulation. The
Figure 3 (See legend on next page.)
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Figure 3 Effect of GR on the proliferation of MDA-MB 231 and MCF-7 BIBR 1532 treated cells. The cells were seeded at a very
low density in a 25 cm2 flask and grown in DMEM culture medium containing 10% FBS and 1% Pen/Strep at different glucose
concentrations with or without 2.5 μM of BIBR 1532. The medium was replaced every two days, and fresh telomerase inhibitor was
added each time. At the end of each week, the cells were split and counted at least three times using bromophenol blue and a
hemocytometer. a and b show the effect of GR and treatment with 2.5 μM BIBR 1532 on MDA-MB 231 and MCF-7 cells based on the
obtained cell number after each count compared to the number seeded cells. Bars represent values from at least three independent experiments
(*p < 0.05, *p < 0.01).
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trations and then treated with 10 and 50 μM BIBR 1532
over 48 h. The results demonstrated that GR displayed
the same profile as those exhibited by the two breast
cancer cell lines. Reducing the glucose concentration in
the media decreases the WST-1 transformation by 40%
and more than 80% for cells grown in 1 g/L and 0 g/L
glucose, respectively (Figure 5c). As shown in Figure 5d,
BIBR 1532 exhibits the same effect in Saos-2 cells
grown in 1 and 4.5 g/L glucose (P = 0.017 and P = 0.0032,
respectively).
hTERT mRNA silencing did not affect mitochondrial
metabolism
To further validate the results concerning the modula-
tion of mitochondrial metabolism by BIBR 1532, we
treated MDA-MB 231 and MCF-7 cells grown at differ-
ent glucose concentrations with TERT siRNA. Surpris-
ingly, Figure 6(a, b) shows that 20 nM TERT siRNA did
not affect the formazan dye formation compared to the
control at the three different glucose concentrations;
however, a decreased tendency was evident only in cells
incubated in 4.5 g/l glucose. The transfection efficiencyFigure 4 Effect of GR on cell viability and mitochondrial metabolism. Th
were equally seeded in 96-well plates at a density of 104 cells/well. Twenty-fou
for 60 minutes at 37°C. The formation of formazan dye was assessed using an
Bars represent values from at least three independent experiments. (*p < 0.05was confirmed by using electrophoresis and cell death
control, which is a blend of highly potent siRNAs target-
ing ubiquitously expressed human genes indispensable
for cell survival (Figure 6) and hTERT gene expression.
This apparently discrepant result could be explained by
a high residual telomerase activity even after partial
hTERT mRAN silencing. Furthermore, hTERT siRNA
likely did not elicit an effect similar to that of BIBR 1532
due to the insufficient incubation time to deplete hTERT.
Glucose deprivation induced apoptosis mediated by BIBR
1532
To demonstrate whether BIBR 1532 induced apoptosis
in MDA-MB 231 and MCF-7 cells, the expression of
caspase-3 was assessed via ELISA (Invitrogen).
Although apoptotic signals are believed to be mediated
by a hierarchy of caspase activation, only two pathways
of caspase activation have been described. Nevertheless,
caspase-3 is a common downstream enzyme activated in
apoptosis that is induced by most stimuli.
The level of caspase-3 was measured in cells grown at
different concentrations of glucose in the presence and
absence of a high concentration of BIBR 1532 (50 μM).e MDA-MB 231 cells grown in DMEM with different glucose concentration
r hours later, cells received 10 μl of tetrazolium salt and were incubated
ELISA reader at 450 nm. The O.D. of each condition is a mean of 12 wells.
and **p < 0.01).
Figure 5 Proliferation test of MDA-MB 231, MCF-7 and of saos-2 cells. Cells grown in DMEM with different glucose concentrations were
equally seeded in 96-well plates at a density of 104 cells/well. Twenty-four hours later, the cells were treated with different concentrations of BIBR
1532 for 48 hours. At the end of treatment, each well received 10 μl of tetrazolium salt and was incubated for 60 minutes at 37°C. The formation
of formazan dye was assessed using an ELISA reader at 450 nm. a and b represent the dose response curves of MDA-MB 231 and MCF-7 to BIBR
1532, respectively. c represents the effect of GR, while d represents the effect of BIBR 1532 on the mitochondrial metabolism of saos-2 cell line.
The O.D. of each condition is a mean of 12 wells. Bars represent values from at least three independent experiments (*P < 0.05, **P < 0.01).
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affect MDA-MB 231 apoptosis except in cells grown in
0 g/l of glucose. Caspase-3 was not expressed in MCF-7
cells, and this result confirmed several reports that indi-
cated caspase-3 deficiency in this cell line.
Caspase-3 expression was not detected in the Saos-2
cell line incubated at different glucose concentrations or
treated with BIBR 1532. (Data not shown).
The results obtained from this experiment suggest that
caspase-3 is involved in the induction of apoptosis in
BIBR 1532-treated MDA-MB 231 cells that are deprived
of glucose. Apoptosis induction was also investigated via
annexin V staining. Figure 8 and Tables 1 and 2 shows
same results displayed in Figure 7. The percentage of
annexin V-positive cells significantly increased in treated
cells with BIBR 1532 without glucose compared to the
control cells. These data suggest that the growth inhibi-
tory effect of BIBR 1532 on MDA-MB 231 cells is partly
due to its effect on apoptosis induction under restricted
glucose conditions. In the MCF-7 cell line, high concen-
trations of BIBR 1532 did not elicit apoptosis as ob-
served in MDA-MB 231, unless cells incubated in highglucose concentration (4.5 g/L) are treated with 50 μM
BIBR 1532, as shown in Figure 8b and Tables 1 and 2.
Discussion
Due to its major role in cell immortalization, telomerase
has become an attractive target for selective cancer ther-
apy. Several approaches have been studied to decrease
or completely inhibit the activity of telomerase. Among
these efforts, we mention the direct and indirect inhibition
of telomerase, immunotherapy using hTERT as a tumor-
associated antigen, and gene therapy with a promoter-
driven suicide promoter [27]. Because its expression is
mainly restricted to tumor cells and it is the rate-limiting
subunit in telomerase activity, hTERT has become the
main target of inhibition to stop tumor growth. However,
these efforts directly face a major obstacle described by
the lag phase between the initiation of telomerase inhib-
ition and the impact on the proliferation capacity [29,30].
Therefore, tumor cells with long telomeres will continue
to grow upon telomerase inhibition until substantial telo-
mere erosion has occurred. This limitation negatively im-
pacts the application of this inhibition in patients with a
Figure 6 Effect of telomerase siRNA on cell viability and mitochondrial metabolism. MDA-MB 231 (a) and MCF-7 (b) cells grown in DMEM
with different glucose concentrations were equally seeded at a density of 2 × 104 in a 96-well plate 10 min after 20 nM SiRNA transfection.
Seventy-two hours later, each well received 10 μl of WST-1 and was incubated for 60 minutes at 37°C. The formation of formazan dye was
assessed using an ELISA reader at 450 nm. The O.D. of each condition is a mean of 12 well. Bars represent values from at least three independent
experiments. (*P < 0.05, **P < 0.01).
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two molecules have been extensively studied: BIBR 1532
(2-((E)-3-naphtalen-2-yl-but-2-enolylamino)-benzoic acid)
and Costunolide. The beneficial effect of caloric restric-
tion, especially GR, on life span extension and cancer pre-
vention and treatment has been very well documented.
However, cell metabolic changes during this stress, es-
pecially on the enzymes activities, are not completely
understood [3].In the present study, we investigated the effects of
BIBR 1532 on cell proliferation, mitochondrial metabol-
ism, and apoptosis in MDA-MB 231 and MCF-7 cells
under restricted glucose conditions. Furthermore, the
role of GR on the telomerase activity and cell division
rate was assessed for extended periods.
Our in vitro study showed that cell glucose deprivation
dramatically decreases the telomerase mRNA expression
and activity and cell proliferation. The important role of
Figure 7 Effect of high BIBR 1532 concentration on cell apoptosis. MDA-MB 231 cells grown at different glucose concentrations were seeded
in 6-well plates at a density of 2 × 105 cells per well. After adherence, the cells were treated with 50 μM BIBR 1532 for 48 hours. After treatment,
the culture media was discarded, and the cells were harvested and lysed as mentioned in materials and methods to further quantify the
caspase-3 level via ELISA and measure the protein concentration. Bars represent values from at least three independent experiments (*p < 0.05).
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previous studies that reported a correlation between cal-
oric restriction and cancer prevention and treatment.
The cells incubated in 0 g/l of glucose were actually ex-
posed to 0.65 g/l from FBS, which perfectly matches the
physiological glycaemia in fasting state, whereas 1 g/l
glucose mimics a postprandial state and 4.5 g/l mimics
non-controlled glycaemia in diabetic patients or constant
high glucose consumption. The increased telomerase ac-
tivity in the presence of high glucose concentrations
could at least partly explain the association between dia-
betes and cancer predisposition [31,32].
Despite the similar hTERT expression in cells grown
in 1 and 0 g/l of glucose, a complementary experiment
involving the cell count showed different results. In fact,
cells grown in media containing 4.5 and 1 g/l of glucose
were relatively similar, with minor significant differ-
ences in the cell number compared to cells grown in
0 g/l of glucose.
To confirm the role of telomerase on mitochondrial
metabolism, a WST-1 assay was performed on a cell line
negative for human telomerase (Saos-2). The same pat-
tern in the mitochondrial metabolism that was observed
for MDA-MB 231 and MCF-7 cells was found in the
osteosarcoma cell line Saos-2. The same experiments
were extended to investigate the effect of BIBR 1532
under restricted glucose conditions. We began by examin-
ing the effect of this inhibitor on cell proliferation. The
MDA-MB 231 cell number reduced to almost zero when
the cells were treated with BIBR 1532. These results couldbe explained by an increased vulnerability of telomerase
to its inhibitor in response to GR.
Mitochondria are important organelles specified in en-
ergy production and cellular calcium homeostasis, and
the capacity to release apoptotic proteins (members of
the Bcl-2 family) is of important consideration [33].
Moreover, mitochondria are considered to be a major
intracellular source of ROS. Succinate dehydrogenase
(SDH), also known as quinone oxidoreductase, is a key
regulator of metabolism and aerobic energy production.
It couples the oxidation of succinate in the citric acid
cycle to the reduction of ubiquinone in the electron
transport chain, allowing cells to rely more on mito-
chondrial oxidative phosphorylation (OXPHOS) than
aerobic glycolysis. Thus, this enzyme could reflect the
activity of the mitochondrial respiratory chain [34]. Cell
oxidative stress is produced with increased OXPHOS.
These ROS have been implicated as second messengers
in multiple signaling pathways, especially in apoptosis,
as indicated by many reports [35]. We suggest that cells
become more dependent on the Warburg effect than on
OXPHOS after reducing the dehydrogenase activity via
BIBR 1532 in 1 and 4.5 g/L of glucose. Aerobic glycolysis
allows cells to rapidly multiply and contributes to ROS
detoxification because carbons are diverted into the pen-
tose phosphate pathway (PPP). This mechanism helps
cancer cells survive under oxidative stress [36].
In MDA-MB 231, a high BIBR 1532 concentration did
not stimulate apoptosis, as assessed by caspase-3 meas-
urement, except for cells grown in 0 g/l of glucose
Figure 8 FACS analysis of BIBR 1532-treated a. MDA-MB 231 and b. MCF-7 cells. Cells were treated with 50 μM BIBR 1532 for 48 h and
subsequently stained for Annexin-V and PI. The results represent three experiments.
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could be explained by the extra-telomeric function of tel-
omerase, i.e. its anti-apoptotic role [37]. The remaining
telomerase activity (~20%) could sustain the proliferative
capacity of cells grown in low glucose. The additive re-
duction activity of telomerase enhanced by BIBR 1532treatment rendered cells more susceptible to apoptotic
signals triggered by this inhibitor and was sufficient to
induce caspase-3 expression in MDA-MB 231 cells. The
absence of apoptosis mediated by the telomerase inhib-
ition in MCF-7 cells is likely due to the up-regulation of
hTERT by the estrogen receptor [38]. Further studies
Table 1 Percentage of apoptotic MDA-MB 231 cells
treated with high BIBR 1532 concentration cells
Cell line Treatment % of apoptotic cells
MDA 0 g/L Control 5.68%
MDA 0 g/L BIBR 1532 (50 μM) 14.57%
MDA 1 g/L Control 8.11%
MDA 1 g/L BIBR 1532 (50 μM) 2.8%
MDA 4.5 g/L Control 3.1%
MDA 4.5 g/L BIBR 1532 (50 μM) 4.24%
(n = 3, mean ± SD).
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1532-mediated telomerase inhibition in the MCF-7 cell
line.
Our results again suggest the importance of GR to in-
hibit telomerase action; an additive effect between GR and
telomerase inhibition by BIBR 1532 is also evident in
apoptosis initiation in the triple-negative cell line MDA-
MB 231.
Conclusions
This report demonstrated that the telomerase inhibitor
BIBR 1532 exhibits an apoptotic effect via telomerase inhib-
ition that is potentiated by restricted glucose conditions.
Materials and methods
Cell culture and glucose restriction
The established human triple-negative breast carcinoma
cells (MDA-MB 231), human-estrogen positive breast
carcinoma cells (MCF-7) and human negative telomerase
osteosarcoma cells (saos-2) were purchased from ATCC
(American Type Culture Collection). All MDA-MB 231,
MCF-7, and Saos-2 cells were cultured in DMEM (Dulbecco’s
modified eagle’s media, Sigma-Aldrich) at different glucose
concentrations (0, 1 and 4.5 g/l) and supplemented with
10% FBS (fetal bovine serum, Sigma-Aldrich, Taufkirchen,
Germany), 1% Pen-Strep (penicillin-streptomycin, Sigma-
Aldrich, Taufkirchen, Germany) and 2 mM glutamine
(Sigma-Aldrich, Taufkirchen, Germany) and maintained
in a humidified atmosphere of 5% CO2 at 37°C. The
cells were pre-incubated for five days in the appropriateTable 2 Percentage of apoptotic MCF-7 cells treated with
high BIBR 1532 concentration
Cell line Treatment % of apoptotic cells
MCF-7 0 g/L Control 7.61%
MCF-7 0 g/L BIBR 1532 (50 μM) 4.79%
MCF-7 1 g/L Control 8.61%
MCF-7 1 g/L BIBR 1532 (50 μM) 9.23%
MCF-7 4.5 g/L Control 5.24%
MCF-7 4.5 g/L BIBR 1532 (50 μM) 8.46%
(n = 3, mean ± SD).media, and treatment occurred when cells reached 80%
confluence.
Cell count
MDA-MB 231 AND MCF-7 cells were seeded at very
low densities in 25 cm2 flasks and grown in DMEM culture
media containing 10% FBS and 1% Pen/Strep at different
glucose concentrations with or without 2.5 μM of BIBR
1532. The medium was replaced every two days, and fresh
telomerase inhibitor was added each time. At the end of
each week, the cells were split and counted at least three
times using bromophenol blue and a hemocytometer.
Figures 3a and b show the effect of GR and treatment
with 2.5 μM BIBR 1532 on MDA-MB 231 and MCF-7
cells by calculating the obtained cell number after each
count on those seeded.
Cell viability and mitochondrial metabolism assay
The cell proliferation was evaluated using WST-1 (Takara
Bio Inc, Ostu, Shiga, Japan), a tetrazoluim salt, cleaved
into formazan by succinate-tetrazolium reductase, which
exists only in the mitochondrial respiratory chain and is
active only in viable cells. The production of formazan is
directly related to the cell number due to the active mito-
chondrial metabolism and to its absorbance, which was
measured using an ELISA reader at 450 nm. In our study,
cells grown in different glucose concentrations were
seeded in 96-well plates at a density of 104 cells per well
and allowed to adhere for 24 hours, and the assay was per-
formed following the manufacturer’s instructions.
Telomerase activity assay
MDA-MB 231 and MCF-7 extracts, from 1.5 million
cells for each condition, were prepared according to the
manufacturer’s protocol using a Quantitative Telomerase
Detection Kit (Allied Biotech, Inc Vallego, California,
USA). Briefly, the cell pellets were washed twice with
cold PBS, and the cells were then lysed with an appropri-
ate volume of the provided lysis buffer. After 30 minutes
of incubation on ice, the suspension was centrifuged for
30 min at 4°C and 12000 × g. The supernatant was then
aliquoted to further assess the telomerase activity and pro-
tein concentration.
The telomerase activity was measured by Real-Time
Polymerase Chain Reaction (PCR) (Applied Biosystem,
USA), which is based on the ability of telomerase in the
cell extracts to synthesize telomeric repeats onto an oligo-
nucleotide substrate, and the resultant extended products
are subsequently amplified by PCR. The generated PCR
products were then visualized using the highly sensitive
DNA fluorochrome SYBR Green. The PCR products were
detected following the binding of SYBR Green dye to
double-strand DNA.
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Total RNA from MDA-MB 231 and MCF-7 cells was ex-
tracted using THE QIAamp RNA extraction Kit (Qiagen
Inc., Valencia, CA, USA). Complementary DNA (cDNA)
was synthesized from 0.1 to 2.5 μg of total RNA in a 20-μl
reaction using the Omniscript Reverse Transcription
Kit (Qiagen Inc., Valencia, CA, USA). The expression
of hTERT and GAPDH was assessed using the multiplex
hTERT/GADPH PCR technique and specific primers. The




aldehyde 3-phosphate dehydrogenase): 5′-TGGGATGGA
CTGTGGTCATGAG-3′, 5′-ACTGGCGTCTTCACCAC
CATGG3-′, which was used as the internal control. PCR
amplification was performed using Dream Taq Green
PCR 2× Master Mix (Fermentas, USA), and the reactions
were subjected to 40 PCR cycles (BioRad, Germany) of
94˚C for 30 seconds, 60˚C for 30 seconds, and 70˚C for
30 seconds followed by 7 minutes of extension at 72˚C.
The PCR products were separated via 1.2% agarose gel
electrophoresis and visualized by ethidium bromide stain-
ing using the UVP BioDoc system (UVP, England).
Protein quantification
The protein concentration was measured with the Bradford
method according to the manufacturer’s recommendations
using an acidic solution of Coomassie Blue G-250 dye,
which is a reagent in the Bio-Rad Protein Assay, and BSA,
which served as the standard. Serial dilutions of BSA at
known concentrations were prepared. Five milliliters of
Coomassie Blue solution (5× diluted) were added to the
diluted proteins. The absorbance of the colored solution
was measured with a spectrophotometer at 595 nm.
Caspase-3 apoptosis assay
The caspase-3 level was determined using a caspase-3
(active) human ELISA Kit from Invitrogen. Briefly, MDA-
MB 23, MCF-7 and saos-2 cells were seeded in 6-well
plates in DMEM at different levels of GR and treated with
50 μM BIBR 1532. After 48 hours of treatment, the cells
were collected in cold phosphate buffered saline 1 × (PBS)
and lysed with cell extraction buffer (10 mM Tris, pH 7.4,
100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF,
20 mM Na4P2O7, 2 mM Na3VO4, 1% Triton X-100, 10%
glycerol, 0.1% SDS, 0.5% deoxycholate, 1 mM PMSF and
protease inhibitor cocktail). The cell extracts were then
used to determine the concentration of caspase-3. The
ELISA method was based on the fixation of cleaved
caspase-3 at Asp 175/Ser 176 between two antibodies.
This enzyme was detected after a detection antibody
bound to the second antibody, followed by adding a
substrate solution that was acted upon by the boundenzyme to produce color. The O.D. (optical density) of
this colored product was measured at 450 nm with an
ELISA Reader (Thermo Scientific, USA), and this O.D.
is directly proportional to the concentration of human
active caspase-3 present in the sample.Annexin V-FITC apoptosis assay
The FITC annexin V apoptosis detection kit (Abcam)
was used following the manufacturer’s instructions. MDA-
MB 231 and MCF-7 cells grown in different glucose con-
centrations were plated at a density of 2 × 105 cells/well
on six-well plates. After 48 h of treatment with 50 μM
BIBR 1532, the cells were trypsinized and collected in ice
cold PBS. The cells were washed twice with cold PBS and
re-suspended in 500 μL binding buffer containing 5 μL
Annexin V-FITC. The signals were detected using a
FACScan flow cytometer (MACSquant, Germany) with
excitation and emission settings of 452 nm.TERT siRNA transfection
MDA-MB 231 and MCF-7 cells were maintained in
DMEM at different concentrations of glucose and plated
in 96-well plates at a density of 2 × 104 cells per well.
Prior to seeding, 5 μL of specific siRNA, Hi-perfect (Qiagen)
and serum-free media were added into each well and incu-
bated for 10 minutes at ambient temperature. One hundred
microliters of cell suspension were added to each well to
initiate a treatment of 72 h. Two siRNAs were used in this
assay; the first was TERT3, which targets the mRNA of
the sub-catalytic unit of telomerase and the second was
Death, which targets expressed human genes that are in-
dispensable for cell survival. This siRNA was used as a
positive control because it induces cell death that was vis-
ible by light Microscopy. The siRNA sequences were de-
signed with the RNAi Human/Mouse Starter Kit (Qiagen
Inc., Valencia, CA, USA). For hTERT, the siRNA sense
sequence was 5′-GGAGCAAGUUGCAAAGCAUTT-3′
and the anti-sense was 5′-AUGCUUUGCAACUUGCU
CCAG-3′, the target sequence was 5′-CTGGAGCAA
GTTGCAAAGCAT-3′. Transfection monitoring was as-
sured by the cell death control siRNA, which is a blend of
siRNAs that target human genes essential for cell survival.Statistical analysis
The statistical analysis was performed with t-test using
the online statistical software Graph-Pad Quickcalcs
(http://www.graphpad.com/quickcalcs/ttest1.cfm).Ethical committee
This project was approved by the Ethical Committee of
the Faculty of Medicine of Saint-Joseph University,
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